Mesoblast Ltd. (MESO)
18.18
+1.34
(+7.96%)
USD |
NASDAQ |
Aug 27, 16:00
18.18
0.00 (0.00%)
After-Hours: 20:00
Mesoblast Net Income (Quarterly)
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2023 | -21.59M |
| March 31, 2023 | -18.60M |
| December 31, 2022 | -24.49M |
| September 30, 2022 | -16.70M |
| June 30, 2022 | -21.46M |
| March 31, 2022 | -21.38M |
| December 31, 2021 | -25.94M |
| September 30, 2021 | -22.64M |
| June 30, 2021 | -21.93M |
| March 31, 2021 | -26.52M |
| December 31, 2020 | -25.69M |
| September 30, 2020 | -24.54M |
| June 30, 2020 | -32.61M |
| March 31, 2020 | -15.26M |
| December 31, 2019 | -24.58M |
| September 30, 2019 | -5.484M |
| Date | Value |
|---|---|
| June 30, 2019 | -20.73M |
| March 31, 2019 | -24.97M |
| December 31, 2018 | -24.60M |
| September 30, 2018 | -19.50M |
| June 30, 2018 | -20.83M |
| March 31, 2018 | -21.14M |
| December 31, 2017 | 13.70M |
| September 30, 2017 | -7.022M |
| June 30, 2017 | -27.18M |
| March 31, 2017 | -9.784M |
| December 31, 2016 | -20.05M |
| September 30, 2016 | -19.80M |
| June 30, 2016 | 48.29M |
| March 31, 2016 | -16.93M |
| December 31, 2015 | -22.32M |
| September 30, 2015 | -13.16M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Immutep Ltd. | -- |
| CSL Ltd. | -- |
| Ceryvyn Therapeutics Ltd. | -- |
| Propanc Biopharma, Inc. | -6.360M |
| Actinogen Medical Ltd. | -- |
Net Income (Quarterly) Related Metrics
| Enterprise Value | 2.403B |
| Earnings Yield | -2.45% |
| Normalized Earnings Yield | -2.847 |